Cargando…

On the Mortality of Companies

Using data from both the US and UK we examine the survival and mortality of companies in both the early stage or start-up and mature phases. The shape of the mortality curve is broadly similar to that of humans. Even small single cellular organisms such as rotifers have a similar shape. The mortalit...

Descripción completa

Detalles Bibliográficos
Autores principales: Richmond, Peter, Roehner, Bertrand M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870919/
https://www.ncbi.nlm.nih.gov/pubmed/35205503
http://dx.doi.org/10.3390/e24020208
_version_ 1784656872140177408
author Richmond, Peter
Roehner, Bertrand M.
author_facet Richmond, Peter
Roehner, Bertrand M.
author_sort Richmond, Peter
collection PubMed
description Using data from both the US and UK we examine the survival and mortality of companies in both the early stage or start-up and mature phases. The shape of the mortality curve is broadly similar to that of humans. Even small single cellular organisms such as rotifers have a similar shape. The mortality falls in the early stages in a hyperbolic manner until around 20–30 years when it begins to rise broadly according to the Gompertz exponential law. To explain in simple terms these features we adapt the MinMax model introduced by the authors elsewhere to explain the shape of the human mortality curve.
format Online
Article
Text
id pubmed-8870919
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88709192022-02-25 On the Mortality of Companies Richmond, Peter Roehner, Bertrand M. Entropy (Basel) Article Using data from both the US and UK we examine the survival and mortality of companies in both the early stage or start-up and mature phases. The shape of the mortality curve is broadly similar to that of humans. Even small single cellular organisms such as rotifers have a similar shape. The mortality falls in the early stages in a hyperbolic manner until around 20–30 years when it begins to rise broadly according to the Gompertz exponential law. To explain in simple terms these features we adapt the MinMax model introduced by the authors elsewhere to explain the shape of the human mortality curve. MDPI 2022-01-28 /pmc/articles/PMC8870919/ /pubmed/35205503 http://dx.doi.org/10.3390/e24020208 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Richmond, Peter
Roehner, Bertrand M.
On the Mortality of Companies
title On the Mortality of Companies
title_full On the Mortality of Companies
title_fullStr On the Mortality of Companies
title_full_unstemmed On the Mortality of Companies
title_short On the Mortality of Companies
title_sort on the mortality of companies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870919/
https://www.ncbi.nlm.nih.gov/pubmed/35205503
http://dx.doi.org/10.3390/e24020208
work_keys_str_mv AT richmondpeter onthemortalityofcompanies
AT roehnerbertrandm onthemortalityofcompanies